P K McGuire
Overview
Explore the profile of P K McGuire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
3584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhattacharyya S, Sainsbury T, Allen P, Nosarti C, Atakan Z, Giampietro V, et al.
Psychol Med
. 2018 Mar;
48(16):2748-2756.
PMID: 29502548
Background: Cannabis and its main psychoactive ingredient δ-9-tetrahydrocannibidiol (THC) can induce transient psychotic symptoms in healthy individuals and exacerbate them in those with established psychosis. However, not everyone experience these...
2.
Stone J, Morrison P, Koychev I, Gao F, Reilly T, Kolanko M, et al.
Psychol Med
. 2016 Sep;
46(16):3443-3450.
PMID: 27655012
Background: Sodium nitroprusside (SNP) has been reported to rapidly reduce psychotic symptoms in patients with schizophrenia. This has the potential to revolutionize treatment for schizophrenia. In this study, we tested...
3.
Pollak T, Beck K, Irani S, Howes O, David A, McGuire P
Psychopharmacology (Berl)
. 2015 Dec;
233(9):1605-21.
PMID: 26667479
Rationale: Autoantibodies to central nervous system (CNS) neuronal surface antigens have been described in association with autoimmune encephalopathies which prominently feature psychiatric symptoms in addition to neurological symptoms. The potential...
4.
Brett C, Peters E, McGuire P
Eur Psychiatry
. 2015 Jan;
30(5):648-54.
PMID: 25614438
Background: The aims of this study were to identify (1) the factor structure of anomalous experiences across the psychosis continuum; (2) qualitative and quantitative differences in psychotic experiences (PEs) between...
5.
Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa J, Kambeitz J, Malhi S, et al.
Eur Neuropsychopharmacol
. 2014 Dec;
25(1):26-37.
PMID: 25532865
Cannabis use can induce acute psychotic symptoms and increase the risk of schizophrenia. Impairments in inhibitory control and processing are known to occur both under the influence of cannabis and...
6.
Bhattacharyya S, Iyegbe C, Atakan Z, Martin-Santos R, Crippa J, Xu X, et al.
Psychol Med
. 2014 Jul;
44(15):3315-28.
PMID: 25065544
Background: What determines inter-individual variability to impairments in behavioural control that may underlie road-traffic accidents, and impulsive and violent behaviours occurring under the influence of cannabis, the most widely used...
7.
Valmaggia L, Day F, Jones C, Bissoli S, Pugh C, Hall D, et al.
Psychol Med
. 2014 Jul;
44(12):2503-12.
PMID: 25055169
Background: Cannabis use is associated with an increased risk of developing a psychotic disorder but the temporal relationship between cannabis use and onset of illness is unclear. The objective of...
8.
Batalla A, Crippa J, Busatto G, Guimaraes F, Zuardi A, Valverde O, et al.
Curr Pharm Des
. 2013 Jul;
20(13):2168-85.
PMID: 23829359
Background: In recent years, growing concerns about the effects of cannabis use on mental health have renewed interest in cannabis research. In particular, there has been a marked increase in...
9.
Valmaggia L, Stahl D, Yung A, Nelson B, Fusar-Poli P, McGorry P, et al.
Psychol Med
. 2013 Feb;
43(11):2311-25.
PMID: 23442767
Background: Many research groups have attempted to predict which individuals with an at-risk mental state (ARMS) for psychosis will later develop a psychotic disorder. However, it is difficult to predict...
10.
Fusar-Poli P, Byrne M, Badger S, Valmaggia L, McGuire P
Eur Psychiatry
. 2012 Nov;
28(5):315-26.
PMID: 23137782
Introduction: Prevention of psychosis has become a major objective of modern clinical psychiatry. An increasing number of new services have been established in Europe and in the world. The OASIS...